Invivyd Stock Quote IVVD - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.32

Bid

1.28

Ask

1.35

Volume

175,884

1.25 Day's Range 1.33

1.05 52 Week Range 5.195

Market Cap

157.497M

Previous Close

1.29

Open

1.33

Last Trade

1.35

Last Trade Time

17:23:44

Financial Volume

$ 227,786

VWAP

1.2951

Average Volume (3m)

429,468

Shares Outstanding

119,315,787

Dividend Yield

PE Ratio

-0.79

Earnings Per Share (EPS)

-1.66

Revenue

Net Profit

-198.64M

Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

invivyd.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Invivyd Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IVVD. The last closing price for Invivyd was $1.29. Over the last year, Invivyd shares have traded in a share price range of $ 1.05 to $ 5.195.

Invivyd currently has 119,315,787 shares outstanding. The market capitalization of Invivyd is $153.92 million. Invivyd has a price to earnings ratio (PE ratio) of -0.79.

Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial

Newly outlined pathway provides a practical, expedient, repeatable immunobridging approach to potential emergency use authorization of serial, novel monoclonal antibodies (mAbs) to prevent and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1	8.19672131148	1.22	1.455	1.1	333785	1.2588927	CS
4	0.2	17.8571428571	1.12	1.48	1.05	359060	1.2089924	CS
12	-1.07	-44.769874477	2.39	2.63	1.05	429468	1.63445812	CS
26	-3.11	-70.2031602709	4.43	5.195	1.05	661270	3.11766373	CS
52	-0.07	-5.03597122302	1.39	5.195	1.05	753612	3.23109803	CS
156	-3.38	-71.914893617	4.7	5.195	0.9802	545817	2.91113387	CS
260	-3.38	-71.914893617	4.7	5.195	0.9802	545817	2.91113387	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CGTXCognition Therapeutics Inc	$ 3.46 (45.99%)	4.09M
RNAZTransCode Therapeutics Inc	$ 0.36 (21.79%)	5.93M
NAMSNewAmsterdam Pharma Company NV	$ 22.13 (17.34%)	16.61k
TCTuanChe Ltd	$ 1.93 (16.97%)	640
YIBOPlanet Image International Ltd	$ 3.38 (15.95%)	50.1k
VTVTvTv Therapeutics Inc	$ 12.0634 (-43.10%)	25.22k
CEROCERo Therapeutics Holdings Inc	$ 0.1955 (-23.63%)	1.93M
TGLTreasure Global Inc	$ 1.436 (-22.38%)	46.74k
LUXHLuxUrban Hotels Inc	$ 0.1547 (-19.01%)	1.21M
JCSEJE Cleantech Holdings Limited	$ 1.1001 (-12.69%)	675
SLNASelina Hospitality PLC	$ 0.0262 (-12.67%)	16.66M
RNAZTransCode Therapeutics Inc	$ 0.36 (21.79%)	5.93M
CGTXCognition Therapeutics Inc	$ 3.46 (45.99%)	4.09M
TLTiShares 20 plus Year Treasury Bond	$ 92.98 (-0.01%)	3.9M
NVDANVIDIA Corporation	$ 113.00 (-0.05%)	2.44M